Publication Activity (10 Years)
Years Active: 2018-2024
Publications (10 Years): 104
Publications (10 Years): 104
University of Udine
Affiliation History
University of Udine
Jun 01 2018
Italy
Publications
- Pier Giorgio Cojutti, Manjunath Amit P Pai, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, Federico Pea
- Milo Gatti, Matteo Rinaldi, Cristiana Laici, Simone Ambretti, Antonio Siniscalchi, Pierluigi Viale, Federico Pea
- Milo Gatti, Caterina Campoli, Edoardo Muratore, Tamara Belotti, Riccardo Masetti, Marcello Lanari, Pierluigi Viale, Federico Pea
- Pier Giorgio Cojutti, Manjunath Amit P Pai, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, Federico Pea
- Milo Gatti, Caterina Campoli, Edoardo Muratore, Tamara Belotti, Riccardo Masetti, Marcello Lanari, Pierluigi Viale, Federico Pea
- Pier Giorgio Cojutti, Manjunath Amit P Pai, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, Federico Pea
- Pier Giorgio Cojutti, Manjunath Amit P Pai, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, Federico Pea
- Pasquale Maria Berrino, Milo Gatti, Valeria Rotaru, Lorenzo Bianchi, Fabio Tumietto, Elena Sora, Riccardo Schiavina, Eugenio Brunocilla, Pierluigi Viale, Federico Pea
- Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, Federico PeaComparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP. Antibiotics (Basel, Switzerland) 13 (4) (2024)
- Milo Gatti, Cecilia Bonazzetti, Renato Pascale, Maddalena Giannella, Pierluigi Viale, Federico PeaReal-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin-Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study. Microorganisms 12 (1) (2024)
- Pier Giorgio Cojutti, Manjunath Amit P Pai, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, Federico Pea
- Milo Gatti, Cecilia Bonazzetti, Renato Pascale, Maddalena Giannella, Pierluigi Viale, Federico PeaReal-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin-Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study. Microorganisms 12 (1) (2024)
- Matteo Conti, Beatrice Giorgi, Rossella Barone, Milo Gatti, Pier Giorgio Cojutti, Federico Pea
- Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, Federico PeaComparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP. Antibiotics (Basel, Switzerland) 13 (4) (2024)
- Pier Giorgio Cojutti, Manjunath Amit P Pai, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, Federico Pea
- Matteo Conti, Beatrice Giorgi, Rossella Barone, Milo Gatti, Pier Giorgio Cojutti, Federico Pea
- Pier Giorgio Cojutti, Manjunath Amit P Pai, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, Federico Pea
- Milo Gatti, Caterina Campoli, Edoardo Muratore, Tamara Belotti, Riccardo Masetti, Marcello Lanari, Pierluigi Viale, Federico Pea
- Milo Gatti, Cecilia Bonazzetti, Renato Pascale, Maddalena Giannella, Pierluigi Viale, Federico PeaReal-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin-Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study. Microorganisms 12 (1) (2024)
- Pier Giorgio Cojutti, Manjunath Amit P Pai, Milo Gatti, Matteo Rinaldi, Simone Ambretti, Pierluigi Viale, Federico PeaAn innovative population pharmacokinetic/pharmacodynamic strategy for attaining aggressive joint PK/PD target of continuous infusion ceftazidime/avibactam against KPC- and OXA-48- producing Enterobacterales and preventing resistance development in critically ill patients. The Journal of antimicrobial chemotherapy (2024)
- Pasquale Maria Berrino, Milo Gatti, Valeria Rotaru, Lorenzo Bianchi, Fabio Tumietto, Elena Sora, Riccardo Schiavina, Eugenio Brunocilla, Pierluigi Viale, Federico Pea
- Pier Giorgio Cojutti, Manjunath Amit P Pai, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, Federico Pea
- Pier Giorgio Cojutti, Aaron J Heffernan, Thomas Tängdén, Paola Della Siega, Carlo Tascini, Jason Alexander Roberts, Federico Pea
- Rossella Barone, Matteo Conti, Beatrice Giorgi, Milo Gatti, Pier Giorgio Cojutti, Pierluigi Viale, Federico Pea
- Chun Liu, Pier Giorgio Cojutti, Maddalena Giannella, Marcello Roberto, Beatrice Casadei, Gianluca Cristiano, Cristina Papayannidis, Nicola Vianelli, Pier Luigi Luigi Zinzani, Pierluigi Viale, Francesca Bonifazi, Federico Pea
- Gianpiero Tebano, Giulia la Martire, Luigi Raumer, Monica Cricca, Davide Melandri, Federico Pea, Francesco Cristini
- Pier Giorgio Cojutti, Simone Giuliano, Renato Pascale, Jacopo Angelini, Carlo Tascini, Pierluigi Viale, Federico Pea
- Pier Giorgio Cojutti, Aaron J Heffernan, Thomas Tängdén, Paola Della Siega, Carlo Tascini, Jason Alexander Roberts, Federico Pea
- Carla Troisi, Pier Giorgio Cojutti, Matteo Rinaldi, Cristiana Laici, Antonio Siniscalchi, Pierluigi Viale, Federico Pea
- Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, Federico PeaReal-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration. Antibiotics (Basel, Switzerland) 12 (10) (2023)
- Rossella Barone, Matteo Conti, Pier Giorgio Cojutti, Milo Gatti, Pierluigi Viale, Federico Pea
- Altea Gallerani, Milo Gatti, Andrea Bedini, Stefania Casolari, Gabriella Orlando, Cinzia Puzzolante, Erika Franceschini, Marianna Menozzi, Antonella Santoro, Nicole Barp, Sara Volpi, Alessandra Soffritti, Federico Pea, Cristina Mussini, Marianna Meschiari
- Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, Federico PeaCould an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bloodstream Infections and/or Ventilator-Associated Pneumonia? Antibiotics (Basel, Switzerland) 12 (12) (2023)
- Rossella Barone, Matteo Conti, Pier Giorgio Cojutti, Milo Gatti, Pierluigi Viale, Federico Pea
- Milo Gatti, Giacomo Fornaro, Zeno Pasquini, Andrea Zanoni, Michele Bartoletti, Pierluigi Viale, Federico Pea
- Rossella Barone, Matteo Conti, Beatrice Giorgi, Milo Gatti, Pier Giorgio Cojutti, Pierluigi Viale, Federico Pea
- Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, Federico PeaCould an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bloodstream Infections and/or Ventilator-Associated Pneumonia? Antibiotics (Basel, Switzerland) 12 (12) (2023)
- Carla Troisi, Pier Giorgio Cojutti, Matteo Rinaldi, Cristiana Laici, Antonio Siniscalchi, Pierluigi Viale, Federico Pea
- Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, Federico Pea, Pierluigi Viale
- Milo Gatti, Pierluigi Viale, Federico Pea
- Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, Paolo Gaibani, Maddalena Giannella, Pierluigi Viale, Federico Pea
- Rossella Barone, Matteo Conti, Pier Giorgio Cojutti, Milo Gatti, Pierluigi Viale, Federico Pea
- Milo Gatti, Giacomo Fornaro, Zeno Pasquini, Andrea Zanoni, Michele Bartoletti, Pierluigi Viale, Federico Pea
- Pier Giorgio Cojutti, Simone Giuliano, Renato Pascale, Jacopo Angelini, Carlo Tascini, Pierluigi Viale, Federico Pea
- Chun Liu, Pier Giorgio Cojutti, Maddalena Giannella, Marcello Roberto, Beatrice Casadei, Gianluca Cristiano, Cristina Papayannidis, Nicola Vianelli, Pier Luigi Luigi Zinzani, Pierluigi Viale, Francesca Bonifazi, Federico Pea
- Pier Giorgio Cojutti, Aaron J Heffernan, Thomas Tängdén, Paola Della Siega, Carlo Tascini, Jason Alexander Roberts, Federico Pea
- Rossella Barone, Matteo Conti, Pier Giorgio Cojutti, Milo Gatti, Pierluigi Viale, Federico Pea
- Rossella Barone, Matteo Conti, Pier Giorgio Cojutti, Milo Gatti, Pierluigi Viale, Federico Pea
- Alessandra Oliva, Francesco Giuseppe De Rosa, Malgorzata Mikulska, Federico Pea, Maurizio Sanguinetti, Carlo Tascini, Mario Venditti
- Carla Troisi, Pier Giorgio Cojutti, Matteo Rinaldi, Cristiana Laici, Antonio Siniscalchi, Pierluigi Viale, Federico Pea
- Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, Federico Pea, Pierluigi Viale
- Pier Giorgio Cojutti, Aaron J Heffernan, Thomas Tängdén, Paola Della Siega, Carlo Tascini, Jason Alexander Roberts, Federico Pea
- Gianpiero Tebano, Giulia la Martire, Luigi Raumer, Monica Cricca, Davide Melandri, Federico Pea, Francesco Cristini
- Milo Gatti, Matteo Rinaldi, Cristiana Laici, Antonio Siniscalchi, Pierluigi Viale, Federico PeaRole of a Real-Time TDM-Based Expert Clinical Pharmacological Advice Program in Optimizing the Early Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Beta-Lactams among Orthotopic Liver Transplant Recipients with Documented or Suspected Gram-Negative Infections. Antibiotics (Basel, Switzerland) 12 (11) (2023)
- Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, Federico Pea, Pierluigi Viale
- Rossella Barone, Matteo Conti, Pier Giorgio Cojutti, Milo Gatti, Pierluigi Viale, Federico Pea
- Pasquale Maria Berrino, Milo Gatti, Matteo Rinaldi, Eugenio Brunocilla, Pierluigi Viale, Federico Pea
- Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, Federico Pea, Pierluigi Viale
- Chun Liu, Pier Giorgio Cojutti, Maddalena Giannella, Marcello Roberto, Beatrice Casadei, Gianluca Cristiano, Cristina Papayannidis, Nicola Vianelli, Pier Luigi Luigi Zinzani, Pierluigi Viale, Francesca Bonifazi, Federico Pea
- Pier Giorgio Cojutti, Aaron J Heffernan, Thomas Tängdén, Paola Della Siega, Carlo Tascini, Jason Alexander Roberts, Federico Pea
- Pier Giorgio Cojutti, Giacomo Fornaro, Milo Gatti, Matteo Rinaldi, Paolo Gaibani, Maddalena Giannella, Federico Pea, Pierluigi Viale
- Milo Gatti, Maddalena Giannella, Matteo Rinaldi, Paolo Gaibani, Pierluigi Viale, Federico PeaPharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia. Antibiotics (Basel, Switzerland) 11 (12) (2022)
- Milo Gatti, Maddalena Giannella, Matteo Rinaldi, Paolo Gaibani, Pierluigi Viale, Federico PeaPharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia. Antibiotics (Basel, Switzerland) 11 (12) (2022)
- Pier Giorgio Cojutti, Sara Tedeschi, Milo Gatti, Eleonora Zamparini, Marianna Meschiari, Paola Della Siega, Mazzitelli Maria, Laura Soavi, Raffaella Binazzi, Elke Maria Erne, Marco Rizzi, Anna Maria Cattelan, Carlo Tascini, Cristina Mussini, Pierluigi Viale, Federico Pea
- Milo Gatti, Sara Tedeschi, Filippo Trapani, Stefania Ramirez, Rita Mancini, Maddalena Giannella, Pierluigi Viale, Federico PeaA Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis. Antibiotics (Basel, Switzerland) 11 (8) (2022)
- Mazzitelli Maria, Milo Gatti, Vincenzo Scaglione, Daniele Mengato, Marco Trevenzoli, Andrea Sattin, Federico Pea, Anna Maria Cattelan
- Milo Gatti, Federico PeaThe Cytokine Release Syndrome and/or the Proinflammatory Cytokines as Underlying Mechanisms of Downregulation of Drug Metabolism and Drug Transport: A Systematic Review of the Clinical Pharmacokinetics of Victim Drugs of this Drug-Disease Interaction Under Different Clinical Conditions. Clinical pharmacokinetics 61 (11) (2022)
- Milo Gatti, Maddalena Giannella, Matteo Rinaldi, Paolo Gaibani, Pierluigi Viale, Federico PeaPharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia. Antibiotics (Basel, Switzerland) 11 (12) (2022)
- Maria Sanz-Codina, Milo Gatti, Carla Troisi, Giacomo Fornaro, Zeno Pasquini, Filippo Trapani, Andrea Zanoni, Fabio Caramelli, Pierluigi Viale, Federico Pea
- Milo Gatti, Giulio Virgili, Pier Giorgio Cojutti, Paolo Gaibani, Matteo Conti, Carmelo Sturiale, Federico Pea, Pierluigi Viale
- Milo Gatti, Giacomo Fornaro, Pierluigi Viale, Federico Pea, Maddalena Giannella
- Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, Federico Pea, Pierluigi VialeAn Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by Pseudomonas aeruginosa and Acinetobacter baumannii in Critically Ill Adult Patients. Antibiotics (Basel, Switzerland) 11 (1) (2021)
- Pier Giorgio Cojutti, Alessia Carnelutti, Davide Lazzarotto, Emanuela Sozio, Anna Candoni, Renato Fanin, Carlo Tascini, Federico PeaPopulation Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against Aspergillus fumigatus and Aspergillus flavus in Adult Patients with Invasive Fungal Diseases: Should Therapeutic Drug Monitoring for Isavuconazole Be Considered as Mandatory as for the Other Mold-Active Azoles? Pharmaceutics 13 (12) (2021)
- Milo Gatti, Massimo Andreoni, Federico Pea, Pierluigi Viale
- Milo Gatti, Pier Giorgio Cojutti, Renato Pascale, Tommaso Tonetti, Cristiana Laici, Alessio Dell'Olio, Antonio Siniscalchi, Maddalena Giannella, Pierluigi Viale, Federico Pea
- Massimo Andreoni, Matteo Bassetti, Salvatore Corrao, Francesco Giuseppe De Rosa, Vincenzo Esposito, Marco Falcone, Paolo Antonio Grossi, Federico Pea, Nicola Petrosillo, Carlo Tascini, Mario Venditti, Pierluigi Viale
- Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, Federico Pea, Pierluigi Viale
- Matteo Rinaldi, Pier Giorgio Cojutti, Eleonora Zamparini, Sara Tedeschi, Nicolò Rossi, Matteo Conti, Maddalena Giannella, Federico Pea, Pierluigi Viale
- Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, Federico Pea, Pierluigi Viale
- Giusy Tiseo, Fabio Arena, Silvio Borrè, Floriana Campanile, Marco Falcone, Cristina Mussini, Federico Pea, Gabriele Sganga, Stefania Stefani, Mario Venditti
- Pier Giorgio Cojutti, Matteo Rinaldi, Eleonora Zamparini, Nicolò Rossi, Sara Tedeschi, Matteo Conti, Federico Pea, Pierluigi Viale
- Pier Giorgio Cojutti, Matteo Rinaldi, Eleonora Zamparini, Nicolò Rossi, Sara Tedeschi, Matteo Conti, Federico Pea, Pierluigi Viale
- Pier Giorgio Cojutti, Angela Londero, Paola Della Siega, Filippo Givone, Martina Fabris, Jessica Biasizzo, Carlo Tascini, Federico Pea
- Pier Giorgio Cojutti, Anna Candoni, Davide Lazzarotto, Carla Filì, Maria Zannier, Renato Fanin, Federico Pea
- Piergiorgio Cojutti, Manjunath P Pai, Federico Pea